
Dnipac-SP Tablet
Marketer
Gurgrace Pharmaceuticals
Salt Composition
Aceclofenac (100mg) + Paracetamol (325mg) + Serratiopeptidase (15mg)
Overview Dnipac-SP Tablet
Combiflam-RX tablets combine medications to ease pain and inflammation in conditions such as muscular aches, arthritic joints, and post-surgical discomfort. This effectively manages pain and swelling in illnesses including rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. Dosage and duration of Combiflam-RX should strictly follow your physician's instructions. Administering it with food or milk minimizes stomach irritation. Consistent, timely use enhances efficacy. Continue treatment as directed until your doctor advises discontinuation. Potential side effects include nausea, vomiting, abdominal pain, indigestion, heartburn, elevated liver enzymes, dizziness, somnolence, and diarrhea. For extended treatment, regular monitoring of kidney and liver function, along with blood work, may be necessary. Prolonged use carries risks of serious complications, potentially including gastrointestinal bleeding and renal impairment. Combiflam-RX is contraindicated during pregnancy and lactation.
Uses of Dnipac-SP Tablet
Analgesia
Major Benefits of Dnipac-SP Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Dnipac-SP Tablet with a meal.
Common Side effects of Dnipac-SP Tablet:
- Nausea
- Vomiting
- Stomach pain
- Indigestion
- Heartburn
- Loss of appetite
- Diarrhea
- Dizziness
- Increased liver enzymes
- Drowsiness
How to use Dnipac-SP Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Dnipac-SP Tablet with a meal.
How Dnipac-SP Tablet works:
Aceclofenac, Paracetamol, and Serratiopeptidase are combined in Dnipac-SP Tablets. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), and the antipyretic Paracetamol, reduce pain and fever by inhibiting the release of inflammatory mediators in the central nervous system. Serratiopeptidase, an enzyme, facilitates healing by degrading aberrant proteins within inflamed tissues.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dnipac-SP Tablet and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dnipac-SP Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Dnipac-SP Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Dnipac-SP Tablets might reduce awareness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Dnipac-SP Tablets, as dose modification may be necessary. Severe kidney disease contraindicates Dnipac-SP Tablet use; a physician's consultation is advised.
LiverCAUTION
Patients with liver impairment should use Dnipac-SP Tablets cautiously, potentially requiring dosage modification under medical supervision. Dnipac-SP Tablets are contraindicated for individuals with severe or active liver disease.
What if you forget to take Dnipac-SP Tablet :
Should you forget a Dnipac-SP Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dnipac-SP Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Pain Relievers |
